Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.09 - $20.4 $730 - $13,667
-670 Reduced 5.54%
11,413 $14,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $20.52 $4,090 - $49,371
-2,406 Reduced 16.61%
12,083 $20,000
Q2 2022

Aug 11, 2022

SELL
$1.35 - $2.29 $5,610 - $9,517
-4,156 Reduced 22.29%
14,489 $31,000
Q4 2021

Feb 11, 2022

BUY
$2.13 - $3.46 $39,713 - $64,511
18,645 New
18,645 $43,000
Q4 2019

Feb 14, 2020

SELL
$8.36 - $23.81 $235,409 - $670,465
-28,159 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$9.83 - $14.82 $276,802 - $417,316
28,159 New
28,159 $277,000
Q3 2018

Nov 13, 2018

SELL
$34.41 - $44.23 $359,687 - $462,336
-10,453 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$39.21 - $50.29 $370,769 - $475,542
-9,456 Reduced 47.5%
10,453 $410,000
Q1 2018

May 11, 2018

SELL
$41.7 - $64.16 $854,349 - $1.31 Million
-20,488 Reduced 50.72%
19,909 $978,000
Q4 2017

Feb 14, 2018

BUY
$28.58 - $49.91 $1.15 Million - $2.02 Million
40,397
40,397 $1.83 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.